Analysis of Orthopedic Patients Response to New Pain Modulating Substances and Drugs

Effect of New Pain Modulating Substances in Orthopedics

Sponsors

Lead Sponsor: Rabin Medical Center

Source Rabin Medical Center
Brief Summary

Data of patient reported outcomes (PRO) are collected during treatment with various pain alleviation methods (drugs or substances)

Detailed Description

The study aims at collecting BPI (brief pain inventory) and other PRO of patients in need of pain relief due to chronic orthopedic pain conditions

Overall Status Completed
Start Date January 1, 2015
Completion Date August 1, 2018
Primary Completion Date August 1, 2018
Study Type Observational
Primary Outcome
Measure Time Frame
Brief pain inventory score (BPI) 2 years
Enrollment 100
Condition
Intervention

Intervention Type: Other

Intervention Name: standard medications crossed over to cannabis

Eligibility

Sampling Method: Non-Probability Sample

Criteria:

Inclusion Criteria:

Chronic pain of orthopedic origin treated for at least one year unsuccessfully

Exclusion Criteria:

contra-indication for cannabis treatment

Gender: All

Minimum Age: 18 Years

Maximum Age: N/A

Healthy Volunteers: No

Overall Official
Last Name Role Affiliation
dror robinson, md Principal Investigator head orthopedic research unit
Location
Facility: Hasharon Hospital
Location Countries

Israel

Verification Date

August 2018

Responsible Party

Type: Principal Investigator

Investigator Affiliation: Rabin Medical Center

Investigator Full Name: DROR ROBINSON

Investigator Title: Head Orthopedic Research Unit

Has Expanded Access No
Condition Browse
Patient Data No
Study Design Info

Observational Model: Case-Crossover

Time Perspective: Retrospective

Source: ClinicalTrials.gov